Lucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024
LCIDLucid (LCID) Prnewswire·2024-10-08 19:49

Company to showcase EsoGuard® and EsoCheck® at the conference's Innovation Pavilion NEW YORK, Oct. 8, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that the Company and several of its key executives will be participating in the upcoming The MedTech Conference 2024, the world's foremost annual medical technology event, which will be held Oct ...